Anti-VEGF Injections for Retina Treatment: A Complete Patient Guide – Everything You Need to Know Before an Eye Injection

Has your retina specialist advised an injection inside your eye? Are you frightened by the thought of a needle entering your eye? Do you want to know whether the injection is painful, whether it can damage your eyesight, how many injections you will need and whether your vision can improve?

You are not alone. These are some of the most common questions patients ask when they are advised an intravitreal injection.

The idea of receiving an injection inside the eye can be frightening. Many patients initially refuse treatment or delay it because of fear, misinformation or uncertainty about its benefits.

However, intravitreal Anti-VEGF injections have transformed the treatment of several retinal diseases. They have helped millions of patients preserve their central vision and, in many cases, improve vision that was previously affected by retinal swelling or abnormal blood vessel growth.

At Shantanu Netralaya Eye Hospital, Varanasi, Dr. Shantanu Kumar Gupta, Medical Retina Specialist, provides evaluation and treatment for retinal diseases, including diabetic macular edema, retinal vein occlusion, wet age-related macular degeneration and other conditions requiring intravitreal therapy.

This guide answers the most important questions patients should understand before undergoing an Anti-VEGF injection.

1. What Is an Anti-VEGF Injection?

Anti-VEGF injection is a treatment in which a specially designed medicine is injected directly into the vitreous cavity of the eye.

The vitreous is the transparent, gel-like substance that fills the inside of the eyeball.

VEGF stands for Vascular Endothelial Growth Factor. It is a naturally occurring protein that plays an important role in the formation of new blood vessels.

However, in certain retinal diseases, excessive VEGF activity can cause two major problems:

  • Abnormal blood vessels may develop in or beneath the retina.
  • Existing retinal blood vessels may become excessively leaky, causing fluid accumulation and swelling.

This can damage the macula, the central part of the retina responsible for detailed vision.

Anti-VEGF medicines block the activity of this protein, helping to reduce abnormal blood vessel growth and leakage.

The main objectives of treatment are:

  • Reduce retinal swelling.
  • Control abnormal blood vessel activity.
  • Reduce fluid accumulation in the macula.
  • Prevent further damage to retinal tissue.
  • Preserve existing vision.
  • Improve vision wherever possible.

An important point: Anti-VEGF injections are not ordinary injections given into the white part of the eye for general eye problems. They are specialised retinal treatments delivered into the vitreous cavity under sterile conditions.

2. Why Is Medicine Injected Inside the Eye Instead of Giving Eye Drops or Tablets?

This is a very common question.

Patients often wonder why they cannot simply use eye drops or oral medicines instead of receiving an injection.

The retina is located at the back of the eye. It is difficult to deliver an adequate therapeutic concentration of many medicines to the retina through ordinary eye drops.

Intravitreal injections allow the medicine to reach the inside of the eye directly, close to the retinal structures that require treatment.

This provides a targeted therapeutic effect.

For conditions such as diabetic macular edema, wet AMD and retinal vein occlusion with macular edema, intravitreal Anti-VEGF treatment can be much more effective than relying on eye drops or tablets.

3. Which Eye Diseases Require Anti-VEGF Injections?

Anti-VEGF injections are used in several retinal conditions, but the indication and treatment schedule differ between diseases.

A. Diabetic Macular Edema (DME)

Diabetes can damage the small blood vessels of the retina.

These damaged vessels may leak fluid into the retinal tissue. When fluid accumulates in the macula, the condition is called diabetic macular edema.

The macula is responsible for detailed central vision, including reading, recognising faces and seeing fine details.

Patients may experience:

  • Blurred central vision.
  • Difficulty reading.
  • Distorted images.
  • Difficulty recognising faces.
  • Reduced vision despite wearing the correct spectacles.

Anti-VEGF injections help reduce vascular leakage and macular swelling.

OCT scanning is particularly useful in assessing the extent of macular edema and monitoring the response to treatment.

In many patients with centre-involving diabetic macular edema and visual impairment, Anti-VEGF therapy is an important first-line treatment.

However, not every patient with diabetic retinopathy requires an injection. Treatment depends on the stage of diabetic eye disease and the presence of macular edema or other complications.

Read more about Diabetic Retinopathy Treatment at Shantanu Netralaya.

B. Retinal Vein Occlusion (BRVO and CRVO)

Retinal vein occlusion occurs when a vein carrying blood away from the retina becomes blocked.

There are two major types:

  • BRVO: Branch Retinal Vein Occlusion.
  • CRVO: Central Retinal Vein Occlusion.

The blockage can result in retinal haemorrhages, vascular leakage and macular edema.

When fluid accumulates in the macula, central vision may become blurred or significantly reduced.

Anti-VEGF injections are an important treatment for macular edema associated with both BRVO and CRVO.

Depending on the patient’s condition, other treatments such as steroid injections, retinal laser or observation may also be considered.

The treatment decision depends on the extent of retinal involvement, visual acuity, OCT findings and the presence of complications.

C. Wet Age-Related Macular Degeneration (Wet AMD)

Age-related macular degeneration affects the macula, particularly in older individuals.

There are two broad forms:

Dry AMD: Characterised by progressive degenerative changes in the macula.

Wet AMD: Characterised by abnormal blood vessel growth beneath or around the macula, which can leak fluid or blood.

Wet AMD may cause:

  • Distortion of straight lines.
  • A dark or blurred spot in the centre of vision.
  • Difficulty reading.
  • Difficulty recognising faces.
  • Sudden deterioration of central vision.

Anti-VEGF injections are a major treatment for wet AMD.

Early diagnosis and treatment are important because untreated abnormal blood vessels can cause permanent damage to the macula.

It is important to remember that dry AMD does not routinely require Anti-VEGF injections. Treatment depends on whether abnormal neovascular activity develops.

Read more about Age-Related Macular Degeneration and its treatment.

D. Myopic Choroidal Neovascularisation (Myopic CNV)

People with high myopia can sometimes develop abnormal blood vessels beneath the retina.

This condition is known as myopic choroidal neovascularisation.

It can cause sudden central blurring, distortion and reduced vision.

Anti-VEGF injections are an important treatment option for active myopic CNV.

E. Proliferative Diabetic Retinopathy

In advanced diabetic retinopathy, abnormal new blood vessels may develop on the retina or optic disc.

These vessels are fragile and can bleed, causing vitreous haemorrhage and potentially tractional retinal detachment.

Anti-VEGF injections may be used in selected cases of proliferative diabetic retinopathy, including as an adjunct to pan-retinal photocoagulation or in particular clinical situations.

However, they do not automatically replace retinal laser treatment.

The role of PRP, injections and vitreoretinal surgery depends on the severity of the disease and individual clinical findings.

F. Other Retinal Conditions

Anti-VEGF medicines may also be considered in selected cases involving:

  • Choroidal neovascularisation.
  • Macular edema associated with certain retinal disorders.
  • Selected inflammatory or vascular retinal conditions.
  • Other disorders involving abnormal vascular leakage or neovascularisation.

Not every condition with retinal fluid or swelling requires Anti-VEGF treatment. Correct identification of the underlying disease is essential.

4. Does Every Patient with a Retina Problem Need an Injection?

Absolutely not.

This is one of the most important things patients should understand.

An abnormal OCT report does not automatically mean that an injection is necessary.

For example:

  • Some patients with diabetic retinopathy need regular monitoring and systemic control rather than injections.
  • Some patients with central serous chorioretinopathy may improve with observation and appropriate management of contributing factors.
  • Some patients with dry AMD require monitoring and other appropriate measures rather than Anti-VEGF treatment.
  • Some retinal conditions require laser rather than injections.
  • Some advanced retinal conditions may require surgery.

The decision to inject should be based on the actual diagnosis, visual function, retinal examination and imaging findings.

At Shantanu Netralaya, the aim is to recommend injections only when there is a genuine clinical indication.

5. What Investigations Are Required Before an Anti-VEGF Injection?

Before recommending an injection, your retina specialist may perform several examinations.

1. Visual Acuity Assessment

Your vision is measured separately in each eye.

This provides a baseline against which treatment response can be assessed.

2. Dilated Retinal Examination

The pupils are dilated to allow a detailed examination of the retina and macula.

This helps identify retinal haemorrhages, abnormal blood vessels, swelling and other retinal changes.

3. OCT (Optical Coherence Tomography)

OCT is one of the most important investigations in modern medical retina practice.

It provides detailed cross-sectional images of the retina.

OCT can help identify:

  • Intraretinal fluid.
  • Subretinal fluid.
  • Macular thickening.
  • Cystoid spaces.
  • Retinal structural damage.
  • Changes in the macular layers.

OCT is also extremely useful for monitoring the response after Anti-VEGF treatment.

4. OCT Angiography and Fundus Photography

Depending on the condition, additional imaging may be required.

OCT Angiography helps visualise retinal and choroidal blood flow without injecting dye.

Fundus photography documents retinal changes and allows comparison during follow-up.

5. Fundus Fluorescein Angiography (FFA)

In selected patients, FFA may be required to assess retinal vascular leakage, ischaemia or abnormal blood vessel patterns.

Not every patient requires all these investigations. The choice depends on the clinical diagnosis.

6. What Are the Different Anti-VEGF Medicines Available?

Several medicines are used for intravitreal Anti-VEGF treatment.

They differ in their molecular structure, duration of action, clinical indications, evidence base and cost.

Commonly used medicines include:

1. Ranibizumab

A specifically designed antibody fragment that inhibits VEGF-A.

It has an established role in treating several retinal diseases, including diabetic macular edema, wet AMD and retinal vein occlusion-associated macular edema.

2. Bevacizumab

Originally developed for cancer treatment, bevacizumab is also widely used in retinal practice through intravitreal administration.

Its use for many retinal indications is off-label, and it is generally a more affordable option.

3. Aflibercept

A VEGF-binding fusion protein that inhibits VEGF-A, VEGF-B and placental growth factor.

It is used in several retinal conditions and may allow longer treatment intervals in suitable patients.

4. Brolucizumab

A smaller antibody fragment used for selected retinal conditions, particularly wet AMD.

It has specific safety considerations, including the risk of intraocular inflammation and retinal vasculitis, which should be discussed before treatment.

5. Faricimab

A bispecific antibody that targets both VEGF-A and angiopoietin-2 (Ang-2).

It offers another treatment option in selected retinal diseases and may allow extended treatment intervals in suitable patients.

Which Anti-VEGF Injection Is Best?

There is no single medicine that is best for every patient.

The choice depends on:

  • The underlying retinal disease.
  • Severity of macular edema.
  • OCT findings.
  • Previous treatment response.
  • Expected duration of effect.
  • Availability of the medicine.
  • Cost and insurance coverage.
  • Individual safety considerations.

A more expensive injection is not automatically the best option for every patient.

Your retina specialist should explain why a particular medicine is being recommended and what alternatives are available.

7. Is an Anti-VEGF Injection Painful?

This is probably the biggest fear among patients.

The reassuring answer is that most patients experience very little pain during the procedure.

Before the injection:

  • Numbing eye drops are applied.
  • The eye is cleaned using an antiseptic solution.
  • The eyelids are gently held open using a sterile instrument.
  • The injection is performed using a very fine needle.

Most patients experience a brief sensation of pressure, mild discomfort or awareness of the procedure rather than significant pain.

The actual injection takes only a few seconds.

Many patients later report that the fear before the procedure was much worse than the injection itself.

8. What Happens During a Retina Injection?

An intravitreal injection is generally performed as a day-care procedure.

The usual steps include:

Step 1: Preparation

Your medical history and treatment plan are reviewed.

Inform your doctor about any active eye infection, medication allergies, previous injection complications or significant medical conditions.

Step 2: Anaesthetic Eye Drops

Numbing drops are applied to reduce discomfort.

Step 3: Cleaning and Sterilisation

The eye and surrounding area are prepared with an appropriate antiseptic solution, usually povidone-iodine.

Sterile precautions are essential to reduce the risk of infection.

Step 4: Keeping the Eye Open

A small sterile instrument called a speculum may be used to gently keep the eyelids open.

Step 5: Injection

A very fine needle is introduced through the pars plana into the vitreous cavity, and the medicine is delivered.

Step 6: Post-injection Assessment

The eye may be checked after the procedure depending on the medicine and clinical situation.

Most patients can return home on the same day.

The procedure is usually brief and does not require hospital admission.

9. Can an Injection Inside the Eye Cause Blindness?

This is understandably one of the most frightening questions.

Intravitreal injections are performed to preserve vision and treat retinal diseases that themselves can cause permanent visual loss.

They are generally safe when performed using appropriate sterile protocols by an experienced ophthalmologist.

However, no intraocular procedure is completely risk-free.

Potential complications include:

  • Endophthalmitis (infection inside the eye).
  • Intraocular inflammation.
  • Increased intraocular pressure.
  • Vitreous haemorrhage.
  • Retinal tear or retinal detachment.
  • Injury to intraocular structures, which is rare.
  • Significant reduction in vision due to a serious complication, which is uncommon.

Endophthalmitis is one of the most serious complications, although it is rare.

Strict sterilisation, proper injection technique and timely recognition of warning symptoms are essential.

The potential benefits and risks should always be discussed before treatment.

10. What Should I Expect After the Injection?

Most patients recover quickly.

Some temporary symptoms are common after the procedure, including:

  • Mild irritation.
  • Watering.
  • Foreign-body sensation.
  • A small red spot on the white of the eye.
  • Temporary floaters.
  • Occasional tiny air bubbles in vision.
  • Mild temporary blurring.

These symptoms generally improve over a short period.

Follow the specific instructions provided by your treating ophthalmologist regarding eye drops, hygiene and activities.

When Should I Contact the Doctor Immediately?

Although serious complications are uncommon, certain symptoms should never be ignored.

Seek urgent ophthalmic evaluation if you experience:

  • Severe or increasing eye pain.
  • Sudden reduction in vision.
  • Increasing redness.
  • Marked sensitivity to light.
  • Significant discharge.
  • A sudden increase in floaters.
  • Flashes of light.
  • A curtain or shadow appearing in your field of vision.

These symptoms may indicate infection, inflammation or a retinal complication.

Do not wait for your next scheduled appointment if such symptoms develop.

11. Can I Watch TV or Use My Mobile Phone After an Injection?

In most uncomplicated cases, normal light activities can be resumed after the procedure.

Watching television, using a mobile phone and reading are generally permitted unless your doctor advises otherwise.

You do not need to keep your eyes closed for the entire day.

However, avoid rubbing or pressing the injected eye and follow your doctor’s specific instructions about hygiene and activities.

12. Can I Drive After a Retina Injection?

It is generally advisable to arrange transportation home.

Your vision may be temporarily blurred because of dilating drops, irritation or the procedure itself.

You should resume driving only when your vision is sufficiently clear and you feel comfortable doing so.

13. How Many Anti-VEGF Injections Will I Need?

This is one of the most frequently asked questions.

Unfortunately, there is no fixed number that applies to every patient.

Some patients may need only a few injections, while others require treatment over several years.

The number depends on:

  • The underlying retinal disease.
  • Severity of retinal swelling.
  • OCT findings.
  • Visual response.
  • Duration of disease.
  • Recurrence of fluid or abnormal vascular activity.
  • Type of medicine being used.

Many patients require an initial series of injections at relatively short intervals.

After the disease becomes stable, the interval may be extended.

What Is a Loading Dose?

In certain retinal diseases, treatment begins with a loading phase.

This may involve injections at approximately monthly intervals for an initial series, depending on the medicine and disease.

The purpose is to suppress active vascular leakage and stabilise the retinal condition.

What Is Treat-and-Extend Treatment?

In a treat-and-extend approach, the retina is assessed after treatment.

If the disease is controlled, the interval between injections is gradually increased.

If fluid or disease activity returns, the interval may need to be shortened.

What Is PRN Treatment?

PRN means Pro Re Nata, or treatment when required.

In this approach, the patient undergoes regular monitoring, and injections are given when there is evidence of recurrent or persistent disease activity.

The appropriate strategy varies between diseases and patients.

14. Will I Need Retina Injections for My Entire Life?

Not necessarily.

Some patients require only a limited number of injections, while others need long-term treatment and monitoring.

For example, treatment requirements may differ considerably between diabetic macular edema, wet AMD and retinal vein occlusion.

Some patients achieve long periods of stability with extended treatment intervals.

Others may experience recurrence when treatment is stopped or the interval becomes too long.

The decision to stop or extend treatment should be based on clinical examination and OCT findings, not simply because vision has improved.

Never discontinue treatment or skip a scheduled retinal review without consulting your retina specialist.

15. Will My Lost Vision Come Back After an Anti-VEGF Injection?

This depends on the condition and the extent of retinal damage.

If reduced vision is mainly due to fluid accumulation and macular swelling, treatment may lead to significant improvement.

However, if retinal tissue has already suffered permanent damage due to prolonged swelling, ischaemia, scarring or other complications, complete recovery may not be possible.

The goals of treatment may therefore include:

  • Improving vision.
  • Stabilising existing vision.
  • Reducing retinal swelling.
  • Preventing further damage.
  • Preserving functional central vision.

It is important to have realistic expectations before starting treatment.

Early diagnosis generally provides a better opportunity to preserve retinal function.

16. Can I Stop Injections Once My Vision Becomes Normal?

No, not without consulting your retina specialist.

Improvement in visual acuity does not necessarily mean that the underlying disease has completely resolved.

For example, OCT may continue to show retinal fluid even when the patient feels that vision has improved.

Similarly, abnormal blood vessels may become active again after treatment intervals are extended excessively.

Regular monitoring is important to identify recurrence before significant visual deterioration occurs.

17. Do I Need to Control My Diabetes and Blood Pressure Along with Retina Injections?

Absolutely.

Retinal treatment should not be considered separately from general health management.

In patients with diabetic retinopathy, good control of blood glucose, blood pressure and cholesterol is important.

Anti-VEGF injections can treat retinal vascular leakage and macular edema, but they do not eliminate the underlying systemic effects of diabetes.

Similarly, appropriate blood pressure and cardiovascular risk management are important in patients with retinal vascular occlusions.

Your retina specialist may coordinate with your physician or diabetologist for optimal systemic management.

18. Are Anti-VEGF Injections Required in Both Eyes?

Not necessarily.

Some patients have retinal disease in only one eye, while others have involvement of both eyes.

Treatment is decided separately for each eye according to the clinical findings.

In selected patients, both eyes may require treatment.

Whether injections are given on the same day or on separate days depends on the clinical situation, safety protocols and individual treatment plan.

19. Is Anti-VEGF Injection Covered by Health Insurance or Ayushman Bharat?

Coverage depends on the insurance policy, diagnosis, medicine, treatment setting and applicable package limits.

Some health insurance plans and government healthcare schemes may cover intravitreal treatment when the indication and package requirements are met.

Patients should confirm the applicable coverage and authorisation before treatment.

At Shantanu Netralaya, patients can discuss available cashless and insurance-related arrangements with the hospital team.

Written treatment estimates should be obtained before beginning an injection cycle.

20. Why Is OCT Important After Every Retina Injection?

OCT has become one of the most valuable tools in modern medical retina practice.

It allows the doctor to examine the macula in detail and identify even relatively small changes in retinal fluid.

After an injection, OCT helps determine:

  • Whether retinal swelling has reduced.
  • Whether intraretinal fluid persists.
  • Whether subretinal fluid is present.
  • Whether the macula has become stable.
  • Whether another injection is required.
  • Whether the treatment interval can be extended.

Treatment decisions should consider both visual acuity and retinal anatomy.

A patient may experience symptomatic improvement even when some disease activity persists.

This is why regular follow-up and imaging are essential.

21. Why Choose Shantanu Netralaya for Anti-VEGF Treatment in Varanasi?

Intravitreal injection treatment is not simply about administering a medicine.

It requires accurate diagnosis, interpretation of OCT findings, selection of an appropriate medicine and regular monitoring.

At Shantanu Netralaya, medical retina care is led by Dr. Shantanu Kumar Gupta, with specialised training in medical retina at Guru Nanak Eye Centre, Maulana Azad Medical College, New Delhi.

His clinical training includes retinal laser procedures, fluorescein angiography and intravitreal injections.

Our Approach to Retina Treatment

1. Diagnosis Before Treatment

Not every retinal abnormality requires an injection. The decision is based on the actual diagnosis and clinical indication.

2. OCT-Guided Treatment

Retinal imaging helps assess disease activity and monitor treatment response.

3. Individualised Medicine Selection

Different Anti-VEGF medicines have different properties and costs. Selection is based on the disease, previous response, suitability and patient considerations.

4. Sterile Injection Protocols

Intravitreal injections are performed with appropriate antiseptic preparation and sterile precautions.

5. Regular Follow-up

Monitoring is essential to determine whether another injection is required or whether treatment intervals can be extended.

6. Ethical and Transparent Counselling

Patients are informed about the benefits, risks, expected treatment duration and available alternatives.

Explore our Medical Retina Services in Varanasi for further information.

Frequently Asked Questions About Anti-VEGF Injections

1. Is an Anti-VEGF injection given directly into the retina?

No. The medicine is injected into the vitreous cavity, the gel-filled space inside the eye. From there, it acts on the retinal and macular tissues.

2. Does the injection touch the retina?

No. The injection is delivered through the pars plana into the vitreous cavity. The needle is not intended to touch the retina.

3. How long does the injection procedure take?

The actual injection takes only a few seconds. Preparation, antiseptic cleaning and other steps take additional time. Most patients return home on the same day.

4. Will I see the needle coming towards my eye?

The eye is prepared and positioned so that the procedure can be performed safely. Numbing drops and appropriate positioning help make the experience comfortable. Most patients do not find the procedure as frightening as they initially expect.

5. Can an injection cause cataract?

Cataract formation is not a typical complication of a properly performed intravitreal injection. However, accidental lens injury is a rare possible complication.

6. Can I eat before an Anti-VEGF injection?

Intravitreal injections are generally performed using local anaesthesia and usually do not require fasting. Follow your doctor’s instructions if any additional procedure or anaesthesia is planned.

7. Should I stop blood thinners before an injection?

Do not stop prescribed blood-thinning medicines on your own. Inform your ophthalmologist about all medications you take so that the treatment can be planned appropriately.

8. Can I take my diabetes medicines on the day of the injection?

In general, routine diabetes medicines are continued as prescribed. Follow any specific instructions given by your treating physician.

9. Can Anti-VEGF injections completely cure diabetic retinopathy?

No. Anti-VEGF treatment can help manage certain complications, particularly diabetic macular edema and selected proliferative disease. It does not eliminate diabetes or permanently cure diabetic retinopathy. Regular retinal monitoring and systemic disease control remain essential.

10. What happens if I miss my scheduled injection?

Delaying treatment may allow retinal fluid or abnormal blood vessel activity to return. Contact your retina specialist as soon as possible to arrange reassessment.

11. Are Anti-VEGF injections used for dry AMD?

Not routinely. Anti-VEGF treatment is primarily used for wet or neovascular AMD, where abnormal blood vessels develop and cause leakage or bleeding.

12. Are Anti-VEGF injections better than retinal laser?

Neither treatment is universally better. Injections and laser have different indications. Some patients require injections, some require laser and some benefit from a combination of both.

13. Can I undergo cataract surgery if I am receiving Anti-VEGF injections?

Yes, in many patients cataract surgery can be planned while receiving retinal treatment. However, the timing should be coordinated according to retinal disease activity and the patient’s overall eye condition.

14. Are Anti-VEGF injections safe for long-term use?

They are widely used for chronic retinal conditions. Long-term treatment requires regular monitoring and assessment of potential ocular and systemic risks. The benefits and risks should be reviewed periodically.

Final Message: Do Not Let Fear Prevent You from Protecting Your Vision

An injection inside the eye may sound frightening, but for many patients with retinal disease, it is an important treatment that can help preserve vision.

The most important factors are:

  • Correct diagnosis.
  • Appropriate selection of medication.
  • Sterile injection technique.
  • Timely treatment.
  • Regular OCT monitoring.
  • Good systemic health management.

If your retina specialist has advised an Anti-VEGF injection, ask questions and understand the reason for treatment. Do not refuse or delay a medically necessary injection solely because of fear.

At Shantanu Netralaya, Varanasi, Dr. Shantanu Kumar Gupta provides medical retina evaluation and intravitreal Anti-VEGF treatment with an emphasis on accurate diagnosis, evidence-based management and individualised patient care.

Book a Retina Consultation

Dr. Shantanu Kumar Gupta
MBBS, MS (MAMC, New Delhi), DNB, FICO (Merit)

Medical Retina Specialist and Cataract Surgeon

Shantanu Netralaya Eye Hospital
40, Deen Dayal Colony, Kabir Nagar Road, Near Durgakund, Varanasi – 221005.

Phone: +91 83186 65154

WhatsApp: +91 79058 54244

Website: https://shantanunetralaya.com/

Serving Varanasi, Chandauli, Ghazipur, Jaunpur, Mirzapur, Sonbhadra and neighbouring districts.

Medical Disclaimer: This article is intended for general patient education and awareness. It does not replace an individual retinal examination or personalised medical advice. The need for an injection, choice of medicine, treatment interval and expected outcome depend on the patient’s diagnosis and clinical findings.